{{Rsnum
|rsid=10915846
|Gene=ENAH
|Chromosome=1
|position=225523485
|Orientation=plus
|GMAF=0.2075
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ENAH
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 10.7 | 42.9 | 46.4
| HCB | 4.4 | 32.4 | 63.2
| JPT | 8.0 | 36.6 | 55.4
| YRI | 0.0 | 0.0 | 100.0
| ASW | 1.8 | 12.5 | 85.7
| CHB | 4.4 | 32.4 | 63.2
| CHD | 1.8 | 21.1 | 77.1
| GIH | 1.0 | 18.8 | 80.2
| LWK | 0.0 | 1.8 | 98.2
| MEX | 8.6 | 43.1 | 48.3
| MKK | 0.6 | 16.0 | 83.3
| TSI | 10.8 | 42.2 | 47.1
| HapMapRevision=28
}}

{{PMID|19641378|OA=1
}} The enabled homolog gene polymorphisms are associated with susceptibility and progression of childhood IgA nephropathy.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}
{{on chip | NatGeo2}}